A biomarker is a characteristic that is measured as an indicator of normal biologic
processes, pathogenic processes, or responses to an exposure or intervention, including …

Seizures result from hypersynchronous, abnormal firing of neuronal populations and are the
primary clinical symptom of the epilepsies. Brain tissue from animal models and patients …

MicroRNAs (miRNAs) function cell-intrinsically to regulate gene expression by base-pairing
to complementary mRNA targets while in association with Argonaute, the effector protein of …

Epilepsy is a neurological disorder characterized by an increased predisposition for
seizures. Although this definition suggests that it is a single disorder, epilepsy encompasses …

Clinical diagnosis of Alzheimer's disease (AD) prior to the age of 65 years is classified as
young-onset (YOAD), whereas diagnosis after the age of 65 years is considered late-onset …

MicroRNAs (miRNAs) are a class of endogenous, non-coding, single-stranded RNAs with a
length of approximately 22 nucleotides that are found in eukaryotes. miRNAs are involved in …

Alzheimer's disease (AD) is characterized by a progressive loss of neurons and cognitive
functions. Therefore, early diagnosis of AD is critical. The development of practical and non …

Ninety-four years have passed since the discovery of the Raman effect, and there are
currently more than 25 different types of Raman-based techniques. The past two decades …

Background There are no blood-based molecular biomarkers of temporal lobe epilepsy
(TLE) to support clinical diagnosis. MicroRNAs are short noncoding RNAs with strong …

Post-traumatic epilepsy (PTE) is one of the most devastating long-term, network
consequences of traumatic brain injury (TBI). There is currently no approved treatment that …